D-0714-2022 Class II Terminated
FDA drug recall D-0714-2022 was initiated by Direct Rx on Dec 7, 2021 and is designated Class II. Reason for recall: Defective Container: Leaking containers. The recall status is terminated (terminated Oct 5, 2023). Affected quantity: 312 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 30, 2022
- Initiation Date
- Dec 7, 2021
- Termination Date
- Oct 5, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 312 bottles
Product description
Diclofenac Sodium Topical Solution 1.5%, 150 mL, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534 Mfg. For SOLA Pharmaceuticals Baton Rouge, LA, NDC 61919-675-05
Reason for recall
Defective Container: Leaking containers.
Distribution pattern
Nationwide within the United States
Code information
Lot #: 24MA2010 Exp. 1/31/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0714-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026